A guide for planning community-oriented health care: the health sector resource allocation model.

The objective of this study was to demonstrate the value of a planning model for the design and evaluation of community health services. The health status of Washtenaw County, Michigan was modeled. Data were obtained from the Michigan Department of Public Health, Medstat Systems, and the medical literature for 32 diseases or conditions, representing approximately 85% of causes of death and 56% of medical payments (excluding medication costs). An expanded life-table approach was used for 16 age-and sex-matched cohorts exposed to a disease attack rate, access-to-care rate, case fatality rate, morbidity, and costs. Rates can be modified to reflect changes due to treatment, secular trends, or prevention programs. Two alternative delivery methods were considered to show the potential impact of reducing cardiovascular deaths (worksite initiative), or increasing utilization of services (lay health promotion) on county health status and costs over time. Deaths, bed days, and annual medical payments were the main outcome measurements. Cardiovascular and cancer conditions are and will be the primary causes of death in this population. The most important causes of bed days are musculoskeletal conditions, chronic obstructive pulmonary disease, accidents, strokes, and depression. The major health-care payments are for angina pectoris and/or other cardiac conditions, musculoskeletal conditions, accidents, prenatal care, and/or childbirth, and depression. The two alternative scenarios illustrate how reductions in mortality are not necessarily equated with similar improvements in morbidity or costs. This model presents an overview of the current and projected health status of a community. With such a planning tool, a community can better understand the impact of potential prevention or intervention programs, and help design its health-care system within the constraints of available resources.

[1]  D L Patrick,et al.  Seven chronic conditions: their impact on US adults' activity levels and use of medical services. , 1995, American journal of public health.

[2]  G. Johnson,et al.  Mortality and cataract: findings from a population-based longitudinal study. , 1992, Bulletin of the World Health Organization.

[3]  W. Kannel,et al.  Lens changes and survival in a population-based study. , 1985, The New England journal of medicine.

[4]  T A Karlson,et al.  The incidence of acute hospital-treated eye injuries. , 1986, Archives of ophthalmology.

[5]  R. D'Agostino,et al.  Secular Trends in Stroke Incidence and Mortality: The Framingham Study , 1992, Stroke.

[6]  R. Frye,et al.  Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. , 1990, Mayo Clinic proceedings.

[7]  L. Goldman,et al.  Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. , 1990, JAMA.

[8]  E P Steinberg,et al.  Comparison of uninsured and privately insured hospital patients. Condition on admission, resource use, and outcome. , 1991, JAMA.

[9]  M. Barry,et al.  Epidemiology and natural history of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.

[10]  C G Chute,et al.  Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. , 1988, The New England journal of medicine.

[11]  W. Stehbens,et al.  Review of the Validity of National Coronary Heart Disease Mortality Rates , 1990, Angiology.

[12]  S J Phillips,et al.  Incidence rates of stroke in the eighties: the end of the decline in stroke? , 1989, Stroke.

[13]  Hans-Ulrich Wittchen,et al.  The changing rate of major depression. Cross-national comparisons. Cross-National Collaborative Group. , 1992, JAMA.

[14]  R F St Peter,et al.  Health insurance status and ambulatory care for children. , 1994, The New England journal of medicine.

[15]  S. Henshaw,et al.  What U.S. women think and do about contraception. , 1983, Family planning perspectives.

[16]  C. Raitta,et al.  The prevalence and type of glaucoma in geriatric patients , 1992, Acta ophthalmologica.

[17]  D J Reda,et al.  Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .

[18]  C E Koop,et al.  Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium. , 1993, The New England journal of medicine.

[19]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[20]  F. Mullan Sounding board. Community-oriented primary care: an agenda for the '80s. , 1982, The New England journal of medicine.

[21]  L. Goldman,et al.  Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. , 1991, JAMA.

[22]  E. Fisher,et al.  Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? , 1992, JAMA.

[23]  T. Vinding Visual impairment of age‐related macular degeneration , 1990, Acta ophthalmologica.

[24]  J. Cleeman,et al.  The prevalence of high blood cholesterol levels among adults in the United States. , 1989, JAMA.

[25]  H. Valkenburg,et al.  Estimation of the possible effect of interventive measures in the area of ischemic heart diseases by the attributable risk percentage. , 1977, American journal of epidemiology.

[26]  R. Ernst,et al.  The US economic and social costs of Alzheimer's disease revisited. , 1994, American journal of public health.

[27]  M. Barry,et al.  Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. , 1988, JAMA.

[28]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[29]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[30]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[31]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[32]  R. Kronmal,et al.  The Seattle virus watch. II. Objectives, study population and its observation, data processing and summary of illnesses. , 1972, American journal of epidemiology.

[33]  R. Voelker Population-based medicine merges clinical care, epidemiologic techniques. , 1994, JAMA.

[34]  J. Wittes,et al.  Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. , 1988, JAMA.

[35]  J. Mackenbach,et al.  Competing causes of death: an analysis using multiple-cause-of-death data from The Netherlands. , 1995, American journal of epidemiology.

[36]  James D. Neaton,et al.  Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .

[37]  W. S. Jordan,et al.  Rhinovirus infections in an industrial population. I. The occurrence of illness. , 1966, The New England journal of medicine.

[38]  R. Klein,et al.  Prevalence of glaucoma. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[39]  Iglehart Jk Health policy report. Health care reform. The states. , 1994 .

[40]  K L Linton,et al.  Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[41]  N. Hollenberg,et al.  Quality of Life and Antihypertensive Therapy in Men -- A Comparison of Captopril with Enalapril , 1993 .

[42]  B. Kohler,et al.  The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast Cancer , 1993 .

[43]  E. Kokmen,et al.  Is the prevalence of dementia changing? , 1991, Neurology.

[44]  W. Garraway,et al.  The changing pattern of survival following Stroke. , 1983, Stroke.

[45]  H. Cohen,et al.  Cancer mortality, aging, and patterns of comorbidity in the United States: 1968 to 1986. , 1991, Journal of gerontology.

[46]  C. H. Patrick,et al.  Population impact of mortality reduction: the effects of elimination of major causes of death on the 'saved' population. , 1980, International journal of epidemiology.

[47]  M M Weissman,et al.  Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. , 1984, Archives of general psychiatry.

[48]  E. Eaker,et al.  Trends in nonfatal coronary heart disease in the United States, 1980 through 1989. , 1993, Archives of internal medicine.

[49]  M. Iida,et al.  Prognosis and disability of stroke patients after 5 years in Akita, Japan. , 1990, Stroke.

[50]  J. Wittes,et al.  Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. , 1988, JAMA.

[51]  A. Stewart,et al.  The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. , 1989, JAMA.

[52]  L. Kessler,et al.  The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. , 1986, The New England journal of medicine.

[53]  M. Higgins,et al.  Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. IV. Natural history. , 1974, The Journal of allergy and clinical immunology.

[54]  J. Tielsch,et al.  Visual impairment in a rural Appalachian community. Prevalence and causes. , 1990, JAMA.

[55]  R. D'Agostino,et al.  Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study , 1992, Neurology.

[56]  A. Stewart,et al.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.

[57]  J. Neaton,et al.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[58]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[59]  A. Buist,et al.  Temporal trends in hospital-based episodes of asthma care in a health maintenance organization. , 1993, The American review of respiratory disease.

[60]  W. Kannel,et al.  Precursors of sudden coronary death. Factors related to the incidence of sudden death. , 1975, Circulation.

[61]  G. Lamas,et al.  A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. , 1993, The New England journal of medicine.

[62]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[63]  R. Klein,et al.  Prevalence of cataracts in a population-based study of persons with diabetes mellitus. , 1985, Ophthalmology.

[64]  B. Reeves,et al.  Ocular and vision defects in preschool children. , 1993, The British journal of ophthalmology.

[65]  W. Browner Estimating the impact of risk factor modification programs. , 1986, American journal of epidemiology.

[66]  W. Willett,et al.  Breast cancer (1) , 1992, The New England journal of medicine.

[67]  Fitzhugh Mullan,et al.  Community Oriented Primary Care , 1982 .

[68]  M. C. Leske,et al.  Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. , 1983, American journal of epidemiology.

[69]  A. Wilson,et al.  Demand incidence and episode rates of ophthalmic disease in a defined urban population. , 1992, BMJ.

[70]  A. J. Campbell,et al.  Prevalence of ocular disease in a population study of subjects 65 years old and older. , 1982, American journal of ophthalmology.

[71]  E. Cook,et al.  The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. , 1984, Annals of internal medicine.

[72]  M. Gold,et al.  Health Insurance and Mortality: Evidence From a National Cohort , 1993 .

[73]  B. Rosner,et al.  Middle ear disease and the practice of pediatrics. Burden during the first five years of life. , 1983, JAMA.

[74]  S. Oparil Antihypertensive therapy--efficacy and quality of life. , 1993, The New England journal of medicine.